locametz
novartis europharm limited - gozetotide - radionuclide imaging - greining geislavirkja - Þetta lyf er eingöngu ætlað til greiningar. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
enalapril krka tafla 5 mg
krka sverige ab - enalaprilum maleat - tafla - 5 mg
daren tafla 10 mg
teva b.v.* - enalapril maleate - tafla - 10 mg
enalapril krka tafla 20 mg
krka sverige ab - enalaprilum maleat - tafla - 20 mg
daren tafla 20 mg
teva b.v.* - enalapril maleate - tafla - 20 mg
cerazette filmuhúðuð tafla 75 míkróg
n.v. organon* - desogestrelum inn - filmuhúðuð tafla - 75 míkróg
daren tafla 5 mg
teva b.v.* - enalapril maleate - tafla - 5 mg
dexavit stungulyf/innrennslislyf, lausn 4 mg/ml
vital pharma nordic aps - dexamethasonum natríumfosfat - stungulyf/innrennslislyf, lausn - 4 mg/ml
enalapril krka tafla 10 mg
krka sverige ab - enalaprilum maleat - tafla - 10 mg
enalapril krka tafla 2,5 mg
krka sverige ab - enalaprilum maleat - tafla - 2,5 mg